CHA would like to remind members that Provider Relief Fund (PRF) Period 3 reporting closes on Sept. 30 at 8:59 p.m. (PT).
The Centers for Medicare & Medicaid Services (CMS) is encouraging providers to prepare for the end of the COVID-19 public health emergency (PHE) and the related emergency authority waivers, regulations, enforcement discretion, and sub-regulatory guidance that have given them the flexibilities needed to respond to the COVID-19 PHE.
In mid-December, COVID-19 data will be reported to the Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN). The NHSN will assume responsibility for collecting the data when the Department of Health and Human Services’ contract with TeleTracking expires on Dec. 31.
CHA has worked closely with the California Department of Public Health to create a process that will allow for retroactive weekend and holiday COVID-19 reporting at the state level. To allow for this functionality, CHA is updating the COVID-19 tracker within SmartSheet. These changes will go live on Aug. 24, and hospitals will be able to […]
On Aug. 2, CHA sent a letter to the California congressional delegation urging members to assist in securing reimbursement for hospitals’ pandemic expenses from the Federal Emergency Management Agency (FEMA).
On July 22, the California Department of Health Care Services (DHCS) officially announced that the clock for the retention payment program will begin on July 30 and run until Oct. 28.
When workers at Mayers Memorial Healthcare District in the Shasta County town of Fall River Mills became overwhelmed by the pandemic, the hospital launched an innovative program and hired a wellness coordinator to assess and tend to the needs of other staff. Learn more about the role of the wellness coordinator, whose goal is to […]
One hospital’s solution to a workforce overwhelmed by two years of pandemic: a wellness coordinator who reminds staff they are valued and cared for.
On July 15, the U.S. Department of Health and Human Services (HHS) renewed the COVID-19 public health emergency (PHE) declaration for another 90 days, extending it until Oct. 13.
On July 6, the Food and Drug Administration amended the Emergency Use Authorization (EUA) for Paxlovid, an orally administered COVID-19 therapeutic drug. The amended EUA expressly permits licensed pharmacists to independently order Paxlovid for individual patients under certain conditions.